Biontech Se Asset Turnover Ratio (BNTX), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Biontech Se  (NASDAQ: BNTX)
 

Biontech Se Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Biontech Se's asset turnover ratio has remained unchanged compare to previous quarter at 0.14 in the fourth quarter (Dec 31 2025)

Within sector 53 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from 0 to 3487.

Asset Turnover Ratio Definition



BNTX Asset Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Asset Change 4.75 % -8.46 % -8.46 % -8.46 % -2.51 %
Y / Y Revenue Change 4.32 % - - - -27.96 %
Asset Turnover Ratio (TTM) 0.14 - - - 0.13
BNTX's Total Ranking # 3487 # 0 # # #
Seq. Asset Change 14.44 % 0 % 0 % -8.46 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 54
Healthcare Sector # 509
Overall Market # 3487

Asset Turnover Ratio Statistics
High Average Low
0.21 0.15 0.12
(Dec 31 2020)   (Dec 31 2024)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Teva Pharmaceutical Industries Limited  0.35 $ 14,047.000  Millions$ 39,787.500  Millions
Elanco Animal Health Incorporated  0.35 $ 4,715.000  Millions$ 13,398.000  Millions
Invivyd Inc   0.35 $ 53.426  Millions$ 152.231  Millions
Tenon Medical Inc   0.35 $ 3.944  Millions$ 11.408  Millions
Scynexis Inc   0.35 $ 20.601  Millions$ 59.677  Millions
Biogen Inc   0.34 $ 9,890.600  Millions$ 28,752.575  Millions
Aquestive Therapeutics Inc   0.34 $ 44.545  Millions$ 129.979  Millions
Quanterix Corporation  0.34 $ 137.959  Millions$ 408.757  Millions
Inmed Pharmaceuticals Inc  0.34 $ 4.507  Millions$ 13.450  Millions
The Cooper Companies Inc   0.33 $ 4,151.100  Millions$ 12,394.975  Millions
Xilio Therapeutics Inc   0.33 $ 43.766  Millions$ 131.477  Millions
Regenxbio Inc   0.33 $ 170.441  Millions$ 512.548  Millions
Alcon inc   0.33 $ 10,401.000  Millions$ 31,555.000  Millions
Ionis Pharmaceuticals Inc   0.33 $ 1,013.568  Millions$ 3,081.398  Millions
Dyadic International Inc   0.33 $ 3.090  Millions$ 9.413  Millions
Opus Genetics Inc   0.33 $ 14.196  Millions$ 43.299  Millions
Galapagos Nv  0.33 $ 1,245.718  Millions$ 3,815.300  Millions
Geron Corporation  0.33 $ 183.623  Millions$ 563.892  Millions
Krystal Biotech Inc   0.33 $ 389.130  Millions$ 1,196.675  Millions
Curis Inc   0.33 $ 9.443  Millions$ 29.042  Millions
Qiagen N v   0.32 $ 2,034.495  Millions$ 6,281.232  Millions
Prestige Consumer Healthcare Inc   0.32 $ 1,103.289  Millions$ 3,419.585  Millions
Amarin Corp Plcuk  0.32 $ 213.646  Millions$ 664.098  Millions
Humacyte Inc   0.32 $ 40.803  Millions$ 127.306  Millions
Butterfly Network Inc   0.32 $ 96.734  Millions$ 304.556  Millions
Baird Medical Investment Holdings Limited  0.31 $ 21.884  Millions$ 69.701  Millions
Hutchmed china Limited  0.31 $ 548.512  Millions$ 1,753.097  Millions
Utah Medical Products Inc  0.31 $ 38.001  Millions$ 121.960  Millions
Picard Medical Inc   0.31 $ 4.630  Millions$ 14.970  Millions
Day One Biopharmaceuticals Inc   0.30 $ 158.182  Millions$ 518.750  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.